Crossmark

Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)

Crossref DOI link: https://doi.org/10.1186/s12885-018-4215-y

Published Online: 2018-04-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dhont, Ludovic

Pintilie, Melania

Kaufman, Ethan

Navab, Roya

Tam, Shirley

Burny, Arsène

Shepherd, Frances

Belayew, Alexandra

Tsao, Ming-Sound

Mascaux, Céline
Funding

Funding for this research was provided by:

Fonds De La Recherche Scientifique - FNRS

Televie

Fonds pour la Recherche Médicale dans le Hainaut

Canadian Cancer Society (701595)

Boehringer-Ingelheim Fonds
License Information

Text and Data Mining valid from 2018-04-16
More Information

Article History

Received: 14 August 2016

Accepted: 12 March 2018

First Online: 16 April 2018

Ethics approval and consent to participate

: The UHN Research Ethics Board approved the study protocol (08–0230-TE) and written informed consent was obtained from each patient. The use of widely available cell lines (ATCC, a publicly accessible repository) does not require ethics approval at our Institution. No permission was required to access the data used for this study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.